Strains of penicillin-sensitive and -insensitive Neisseria meningitidis were examined using a range of polymerase chain reaction (PCR) primers directed at the meningococcal penicillinbinding protein 2 gene. DNA from isolates whose penicillin MIC was <0.2 mg/L yielded a product of the expected size with all the primers, but many amplification patterns were seen with DNA from isolates whose MIC was above this level. All strains whose MIC was >0.25 mg/L failed to produce a product of the expected size with at least one of the primers used. The changes seen in penicillin-insensitive strains were consistent with horizontal gene transfer from Neisseria flavescens in some isolates, although the source for others remains unknown. PCR-based methods for the detection of antibiotic resistance are becoming increasingly important with the expanding use of molecular techniques for bacteriological diagnosis.
Introduction
The polymerase chain reaction (PCR) is obviously suited to the diagnosis of infection by slow-growing or fastidious organisms, but its speed, sensitivity and specificity also make it applicable to the detection of a much broader range of pathogens in many different clinical samples. However, the value of any rapid diagnosis may be much diminished unless a simultaneous measurement can be made of antibiotic sensitivity in order to guide the choice of therapy. One example of this is in the case of Neisseria meningitidis, where an increasing number of relatively penicillin-insensitive isolates is being found. Experience has shown that penicillin treatment in some of these cases is associated with a prolonged fever, 1 higher complication rate 2 and treatment failure, 3, 4 and it may be that penicillin can no longer be assumed to be the antibiotic of choice in all cases of meningococcal disease.
It has been shown that most penicillin-insensitive isolates have an altered form of the 59 kDa protein 5 that is now generally referred to as penicillin-binding protein 2 (PBP2) because of its homology to the gonococcal protein.
In support of this, Spratt et al. 6, 7 have demonstrated the transfer of part of the pbp2 gene from the moderately penicillin-resistant Neisseria spp. into N. meningitidis (and Neisseria gonorrhoeae) within penicillin-insensitive strains. In this study, we have used PCR to examine the diversity of pbp2 in strains of N. meningitidis with varying penicillin sensitivity in order to assess the potential for the development of a PCR-based protocol for the detection of penicillin insensitivity that would complement a meningococcus-specific detection system.
Materials and methods
The bacterial isolates used in this study included strains of penicillin-insensitive N. meningitidis from a range of sources as well as freshly isolated local penicillin-sensitive clinical strains, as described in the Samples were prepared for PCR by harvesting the growth from a chocolate agar plate incubated overnight at 35°C, washing twice in 2 mL phosphate-buffered saline (pH 7.4) and then resuspending in 1 mL distilled water. After heating to 100°C for 5 min and centrifuging at 6000g for 2 min, the supernatant was taken off, diluted 1 in 50 with distilled water and stored at 4°C; 10 L of sample was used in each 100 L PCR reaction. Three categories of primers were designed as shown in the Figure: PBP2 gen primers (PBP2.1 and 2.4) were based on consensus regions within the pbp2 genes of Neisseria spp.; the PBP2 flav primer (PBP2.3) was specific to the pbp2 gene of Neisseria flavescens; and the remaining PBP2 sens primers (PBP2.2, 2.5, 2.7, 2.9, 2.10, 2.11 and 2.12) were designed to hybridize to the pbp2 gene in penicillin-sensitive N. meningitidis. Standard PCR protocols were followed 8 using 2 units of Taq polymerase (Boehringer-Mannheim, Lewes, UK or HT Biotechnology Ltd, Cambridge, UK) per 100 L reaction volume using the following parameters: 5 min at 95°C; 30 cycles of 1.0 min at 55°C, 1.5 min at 72°C and 1.0 min at 93°C; 1.0 min at 55°C followed by 5.0 min at 72°C. The expected sizes of PCR amplification products were as follows: PBP2.1/2.9, 444 bp; PBP2.1/2.2, 772 bp; PBP2.1/2.11, 852 bp; PBP2.1/2.12, 978 bp; PBP2.7/2.10, 367 bp; PBP2.7/2.5, 436 bp; PBP2.1/2.3, 985 bp; and PBP2.1/2.4, 358 bp. Product was analysed by ethidium bromide staining following electrophoresis in 2% agarose gels using low molecular size markers spanning 50-1000 
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Results
The result of PCR amplification of DNA from penicillinsensitive and -insensitive strains of N. meningitidis is shown in the 'General' primers designed to hybridize to the PBP2 gene in all Neisseria, with a maximum of 2 bp mismatches to any published sequence.
7 c Primer based upon the sequence of N. flavescens, numbered according to the scheme used by Spratt et al. 6 It was not possible to detect all of the strains with an altered pbp2 gene by the presence or absence of amplification product with any single primer pair. However, this could be achieved by combining the results of two primer pairs, PBP2.1/PBP2.12 with either PBP2.7/PBP2.10 or PBP2.7/PBP2.5.
Discussion
There are now a number of reports of using PCR-based methods for detecting genes associated with antibiotic resistance. These techniques are particularly attractive for slowly growing bacteria such as Mycobacterium tuberculosis, where there are obvious difficulties in culturing isolates and then testing their sensitivity. Protocols have been described for detecting rifampicin resistance directly from clinical samples 9, 10 and, now that the underlying molecular mechanisms of resistance are being established for isoniazid, 11 quinolones 12 and aminoglycosides, 13 methods for other antibiotics will probably follow. Whilst this work is undeniably exciting, most of these studies have involved the use of single-strand conformation polymorphism (SSCP) analysis or DNA sequencing of PCR products, methods which are not readily accessible in most reference laboratories today. By contrast, techniques which rely upon the detection or absence of particular sequences or genes through the presence or absence of a PCR product are much more broadly applicable in a range of laboratories. The PCR-based detection of the mecA gene in staphylococcal isolates is a simple procedure that could now be regarded as the definitive method for identifying methicillin-resistant Staphylococcus aureus. 14 Tenover et al. 15 employed a similar approach to detect ampicillin-resistant Haemophilus influenzae directly within samples of cerebrospinal fluid (CSF). Using primers specific for the bla TEM and bla ROB -lactamase genes, they obtained a product of the expected size from the CSF if infection was caused by -lactamase-producing H. influenzae, but no amplification product was seen if infection was caused by ampicillin-sensitive H. influenzae or by Streptococcus pneumoniae. Ubukata et al. 16 used a PCR-based approach to detect two classes of mutation in the pbp2b gene of penicillin-insensitive S. pneumoniae isolates with some success, particularly for strains with penicillin MICs of 1 mg/L.
Although the penicillin insensitivity in N. meningitidis results from modification in PBP sequence rather than from the acquisition of a completely novel gene, we have tried to avoid the use of techniques such as SCCP which have often been used under these circumstances. Zhang et al. 17 described primers which amplify the entire pbp2 gene to produce a 2 kb product which can then be analysed by restriction endonucleases. However, this large product may not be efficiently amplified if attempted directly from clinical material and it does require radiolabelling of the product for the enzyme digestion pattern to be visualized. Rather, we have used a simple, rapid, PCR-based approach to show that, using multiple sets of primers, it is possible to detect penicillin insensitivity in clinical isolates of N. meningitidis. Five (42%) of the 12 isolates with penicillin MICs between 0.2 and 0.25 mg/L inclusive, and all nine isolates with a penicillin MIC of 0.25 mg/L, were detected by this method. Studies by Spratt et al. 6, 7 have demonstrated sequence mosaics within all the pbp2 genes of penicillin-insensitive strains of N. meningitidis, although the pbp2 sequence within penicillin-sensitive strains appears to be extremely stable. This is most likely to have arisen by horizontal transfer of segments of DNA between Neisseria spp. and the complexity of mosaics suggests that this has not been an infrequent event. Although there are many possible patterns which give rise to penicillin insensitivity, the protocol that we have used appears to be targetting important areas of the gene and it is likely that resistant strains would all be detectable in practice. Additionally, when the available database nucleic acid sequences are examined in the primer regions of the two combinations, PBP2.1/PBP2.12 and either PBP2.7/ PBP2.10 or PBP2.7/PBP2.5, there is a minimum of 4 bp mismatches with at least one primer, so that successful PCR amplification would be unlikely under the stringent conditions used. Indeed, given the established stability in pbp2 sequence amongst penicillin-sensitive strains of N. meningitidis, any detectable change in pbp2 that may be encountered in future clinical strains are likely to be associated with antibiotic insensitivity. It is not possible to predict the penicillin MIC based upon the pattern of PCR amplification, but this method is valuable in that it is able to detect isolates with substantially raised MICs of penicillin, and it is these strains that are most likely to result in clinical treatment failure. Whilst this has not been a common occurrence as yet, there are already two reports of penicillin failure in meningococcal meningitis, 3, 4 an event that is well recognized in pneumococcal infection with insensitive strains. 18 Although, to some extent, it has been overtaken by the problem of antibiotic resistance in S. pneumoniae, penicillin insensitivity remains a problem in N. meningitidis. Blondeau et al. 19 recently described a clonal outbreak with moderately penicillin-resistant strains in Saskatchewan and resistant strains are becoming an increasing problem throughout Spain. 20 The detection of reduced sensitivity to penicillin is not particularly difficult in vitro, but a potential problem arises in cases where infection has not been diagnosed by cultural means. However, the advice given to general practitioners in the UK includes the need to consider giving penicillin to all suspected cases of meningococcal infection before admission, 21 even though this early treatment obviously reduces the likelihood of successful culture. That this is clearly justified in practice is confirmed by the findings of the Research Committee of the British Society for the Study of Infection, 22 who found that the mortality in the group that received antibiotics before hospital admission was just 2%, as opposed to 12% in the group without prior antibiotic therapy. Given these findings, treatment with antibiotics before hospital admission is liable to increase further in the future, and diagnostic laboratories will need to employ new non-culture techniques to guide clinicians with an appropriate choice of antibiotic therapy in bacterial meningitis.
